RVTY — Revvity
Data coverage, completeness and provenance for Revvity in the Stock Market API — Health Care · Diagnostics & Research.
Stored price coverage
Source date: 2026-11-19T21:00:02. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-19 | 151.5900 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 152.4300 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 147.7900 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 148.8500 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-13 | 154.3900 | USD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/RVTY/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Profile
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Employees: 11,000 · Website: https://www.revvity.com · Profile fields populated: 75%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/RVTY/financials.
Financial statement coverage (USD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (USD) | 2025-12-28 | 30 | sec_edgar | ||||
| FY2024 (USD) | 2024-12-29 | 30 | sec_edgar | ||||
| FY2023 (USD) | 2023-12-31 | 30 | sec_edgar | ||||
| FY2022 (USD) | 2023-01-01 | 32 | sec_edgar | ||||
| FY2021 (USD) | 2022-01-02 | 31 | sec_edgar |
Get RVTY data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/RVTY
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/RVTY/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/RVTY/metrics/summary
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/RVTY/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/RVTY
Query RVTY programmatically
Free tier — instant API key. Built for AI agents.
Other NYSE · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for RVTY?
- Stored coverage for RVTY: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/RVTY; inspect available source metadata for provenance.
- How complete is RVTY's financial data?
- The anchor reporting period (FY2025) has 88.2% of the 17 core statement fields populated. Primary source: sec_edgar.
- What reporting periods are covered for RVTY?
- 5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/RVTY/financials.
- Where does RVTY's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/RVTY/financials; missing tags do not establish provenance.